Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia
NCT00383318 is an observational study sponsored by Pediatrix. As of 18 Nov 2026, it is completed. It studies Hyperbilirubinemia and Jaundice. The registry lists an enrollment of 450 participants at 1 site in 1 country. The registry lists a start date of 30 Sept 2006 and a primary completion date of 31 Dec 2007.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00383318 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Pediatrix |
| Enrollment | 450 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Hyperbilirubinemia and Jaundice |
| Start | 30 Sept 2006 |
| Primary completion | 31 Dec 2007 |
| Study completion | 31 Dec 2007 |
| Last update posted | 28 Jan 2008 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Jon Watchko, MD
University of Pittsburgh
Principal Investigator - Reese H Clark, MD
Pediatrix
Principal Investigator - Zhili Lin, PhD, MD
Pediatrix Screening
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Greenville Medical Center
Greenville
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT00383318
Each answer restates registry values shown on this page.
What is NCT00383318?
NCT00383318 is an observational study sponsored by Pediatrix. It studies Hyperbilirubinemia and Jaundice.
Who leads NCT00383318?
The registry names Jon Watchko, MD (principal investigator, University of Pittsburgh), Reese H Clark, MD (principal investigator, Pediatrix) and Zhili Lin, PhD, MD (principal investigator, Pediatrix Screening) as overall officials.
Where does NCT00383318 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT00383318 end?
The registry lists a primary completion date of 31 Dec 2007 and a study completion date of 31 Dec 2007. The sponsor last updated the record on 28 Jan 2008.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.